EUVIMEDEUVIMED entdecken
Crossref

Prognostic Value of Serum Biomarkers in Patients With Moderate-Severe Traumatic Brain Injury, Differentiated by Marshall Computer Tomography Classification

Sophie Richter, Endre Czeiter, Krisztina Amrein, Ana Mikolic, Jan Verheyden, Kevin Wang, Andrew I R Maas, Ewout Steyerberg, András Büki, David K Menon, Virginia F J Newcombe

Journal of Neurotrauma · 2023

DOI: 10.1089/neu.2023.0029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurotrauma, 2023. Verfasst von Sophie Richter und 10 weiteren Autor:innen. Beteiligte Einrichtung: University Division of Anaesthesia, University of Cambridge, Cambridge, United Kingdom. Hauptthemen laut MEDLINE: Brain Injuries, Traumatic. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Wellcome Trust, Department of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prognostication is challenging in patients with traumatic brain injury (TBI) in whom computed tomography (CT) fails to fully explain a low level of consciousness. Serum biomarkers reflect the extent of structural damage in a different way than CT does, but it is unclear whether biomarkers provide additional prognostic value across the range of CT abnormalities. This study aimed to determine the added predictive value of biomarkers, differentiated by imaging severity. This prognostic study used data from the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study (2014–2017). The analysis included patients aged ≥16 years with a moderate-severe TBI (Glasgow Coma Scale [GCS]

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain Injuries, TraumaticHumansMaleAdolescentYoung AdultAdultMiddle AgedAgedAged, 80 and overFemalePrognosisBiomarkersGlasgow Coma ScaleTomography, X-Ray Computed

Stichwörter der Autor:innen

CT scanningadult brain injurybiomarkersprospective studytraumatic brain injury

Substanzen

Biomarkers

Autor:innen und Institutionen

  • University Division of Anaesthesia, University of Cambridge, Cambridge, United Kingdom.
  • Department of Neurosurgery, Medical School, University of Pécs, Pécs, Hungary.
  • Neurotrauma Research Group, Szentágothai Research Centre, University of Pécs, Pécs, Hungary.
  • ELKH-PTE Clinical Neuroscience MR Research Group, University of Pécs, Pécs, Hungary.
  • Department of Psychology, University of British Columbia, Vancouver, British Columbia, Canada.
  • Rehabilitation Research Program, GF Strong Rehabilitation Centre, Vancouver, British Columbia, Canada.

Förderung

  • Wellcome Trust
  • Department of Health

Zitieren

APA

Richter, S., Czeiter, E., Amrein, K., Mikolic, A., Verheyden, J., Wang, K., Maas, A. I. R., Steyerberg, E., Büki, A., Menon, D. K., & Newcombe, V. F. J. (2023). Prognostic Value of Serum Biomarkers in Patients With Moderate-Severe Traumatic Brain Injury, Differentiated by Marshall Computer Tomography Classification. Journal of Neurotrauma. https://doi.org/10.1089/neu.2023.0029

Vancouver

Richter S, Czeiter E, Amrein K, Mikolic A, Verheyden J, Wang K, et al. Prognostic Value of Serum Biomarkers in Patients With Moderate-Severe Traumatic Brain Injury, Differentiated by Marshall Computer Tomography Classification. Journal of Neurotrauma. 2023. doi:10.1089/neu.2023.0029

BibTeX
@article{Richter2023,
  author = {Richter, Sophie and Czeiter, Endre and Amrein, Krisztina and Mikolic, Ana and Verheyden, Jan and Wang, Kevin and Maas, Andrew I R and Steyerberg, Ewout and Büki, András and Menon, David K and Newcombe, Virginia F J},
  title = {Prognostic Value of Serum Biomarkers in Patients With Moderate-Severe Traumatic Brain Injury, Differentiated by Marshall Computer Tomography Classification},
  journal = {Journal of Neurotrauma},
  year = {2023},
  doi = {10.1089/neu.2023.0029}
}
Kostenlos starten →